Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

X Chen, Z Chen, AS Azman, X Deng, R Sun… - The Lancet Global …, 2021 - thelancet.com
Background A rapidly increasing number of serological surveys for antibodies to SARS-CoV-
2 have been reported worldwide. We aimed to synthesise, combine, and assess this large …

Infection fatality rate of COVID-19 in community-dwelling elderly populations

C Axfors, JPA Ioannidis - European Journal of Epidemiology, 2022 - Springer
This mixed design synthesis aimed to estimate the infection fatality rate (IFR) of Coronavirus
Disease 2019 (COVID-19) in community-dwelling elderly populations and other age groups …

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly… - Science, 2021 - science.org
Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of> …

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

MV Murhekar, T Bhatnagar, S Selvaraju… - The Lancet Global …, 2021 - thelancet.com
Background The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serosurvey in India, done in May–June, 2020, among adults aged 18 years or older from …

SARS‐CoV‐2 re‐infection risk in Austria

S Pilz, A Chakeri, JPA Ioannidis… - European journal of …, 2021 - Wiley Online Library
Background A key question concerning coronavirus disease 2019 (COVID‐19) is how
effective and long lasting immunity against this disease is in individuals who were previously …

[HTML][HTML] SARS-CoV-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, South Africa, July 2020–March 2021

J Kleynhans, S Tempia, N Wolter… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be
underestimated because of limited access to testing. We measured SARS-CoV-2 …

[HTML][HTML] SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021

MV Murhekar, T Bhatnagar, JWV Thangaraj… - International Journal of …, 2021 - Elsevier
Abstract Background Earlier serosurveys in India revealed seroprevalence of severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May–June 2020 and 7.1% in …

Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross …

MV Murhekar, T Bhatnagar, JWV Thangaraj… - PLoS …, 2021 - journals.plos.org
Background India began COVID-19 vaccination in January 2021, initially targeting
healthcare and frontline workers. The vaccination strategy was expanded in a phased …

All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study

JA Lewnard, A Mahmud, T Narayan, B Wahl… - The Lancet Infectious …, 2022 - thelancet.com
Background India has been severely affected by the ongoing COVID-19 pandemic.
However, due to shortcomings in disease surveillance, the burden of mortality associated …

The main molecular and serological methods for diagnosing COVID-19: an overview based on the literature

BAS Machado, KVS Hodel, VG Barbosa-Junior… - Viruses, 2020 - mdpi.com
Diagnostic tests have been considered as the main alternative for the control of coronavirus
disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS …